Patent · US Active

Blood-brain barrier comprising engineered endothelial cells

US11786559B2 · kind B2 · utility

0Cited by
13References
20Claims
0Family size

Inventors

Key dates

Filing dateSep 13, 2017
Grant dateOct 17, 2023
Priority date
Expiry dateFeb 24, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2710/10322
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention relates, in part, to blood-brain barrier-like tissues that comprise engineered E40RF1+ endothelial cells, and to various compositions and methods useful for making and using such blood-brain barrier-like tissues—both in vitro and in vivo.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.